Naomi Winick

1992–2024 年に発表

113
論文数
19,774
被引用数
80
h 指数
112
i10 指数

被引用数

Naomi Winick の年別被引用数1993 年: 被引用 5 件1994 年: 被引用 10 件1995 年: 被引用 13 件1996 年: 被引用 8 件1997 年: 被引用 12 件1998 年: 被引用 15 件1999 年: 被引用 20 件2000 年: 被引用 27 件2001 年: 被引用 25 件2002 年: 被引用 21 件2003 年: 被引用 27 件2004 年: 被引用 35 件2005 年: 被引用 34 件2006 年: 被引用 38 件2007 年: 被引用 29 件2008 年: 被引用 40 件2009 年: 被引用 59 件2010 年: 被引用 54 件2011 年: 被引用 65 件2012 年: 被引用 130 件2013 年: 被引用 143 件2014 年: 被引用 163 件2015 年: 被引用 266 件2016 年: 被引用 189 件2017 年: 被引用 188 件2018 年: 被引用 186 件2019 年: 被引用 719 件2020 年: 被引用 808 件2021 年: 被引用 771 件2022 年: 被引用 538 件2023 年: 被引用 360 件2024 年: 被引用 640 件2025 年: 被引用 229 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,931 件、この内訳の 30.7%イギリス: 引用元論文 367 件、この内訳の 5.8%ドイツ: 引用元論文 358 件、この内訳の 5.7%中国: 引用元論文 354 件、この内訳の 5.6%イタリア: 引用元論文 327 件、この内訳の 5.2%カナダ: 引用元論文 264 件、この内訳の 4.2%オランダ: 引用元論文 248 件、この内訳の 3.9%フランス: 引用元論文 208 件、この内訳の 3.3%オーストラリア: 引用元論文 196 件、この内訳の 3.1%日本: 引用元論文 135 件、この内訳の 2.2%スウェーデン: 引用元論文 131 件、この内訳の 2.1%スペイン: 引用元論文 128 件、この内訳の 2%
0%30.7%その他 26.2%

分野

  • Medicine80.5%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Immunology and Microbiology1.4%
  • Materials Science0.5%
  • Neuroscience0.5%
  • その他2%

トピック

  • Acute Lymphoblastic Leukemia research17.8%
  • Childhood Cancer Survivors' Quality of Life9.6%
  • Acute Myeloid Leukemia Research7.1%
  • Chronic Myeloid Leukemia Treatments4.9%
  • CAR-T cell therapy research3.5%
  • Lymphoma Diagnosis and Treatment2.5%
  • その他54.6%

共著者

全論文

検索で開く
  1. The genomic landscape of pediatric acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott G. Foy, Dale J. Hedges, Scott Newman, Xin Zhou, Jian Wang, Colleen Reilly, Edgar Sioson, Stephen V. Rice, Victor Pastor Loyola, Gang Wu, Evadnie Rampersaud, Shalini C. Reshmi, Julie M. Gastier-Foster, Jaime M. Guidry Auvil, Patee Gesuwan, Malcolm A. Smith, Naomi Winick, Andrew J. Carroll, Nyla A. Heerema, Richard C. Harvey, Cheryl L. Willman, Eric Larsen, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler‐McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Stuart S. Winter, Michael J. Burke, Wanda L. Salzer, Kimberly P. Dunsmore, Anne Angiolillo, Kristine R. Crews, James R. Downing, Sima Jeha, Ching‐Hon Pui, William E. Evans, Jun J. Yang, Mary V. Relling, Daniela S. Gerhard, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2022 被引用: 397

  2. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Stuart S. Winter, Brent L. Wood, Brian P. Sorrentino, James R. Downing, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2017 被引用: 934

  3. Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Panduka Nagahawatte, Gang Wu, Xiang Chen, Donald Yergeau, Bhavin Vadodaria, Heather L. Mulder, Naomi Winick, Eric Larsen, William L. Carroll, Nyla A. Heerema, Andrew J. Carroll, Guy H. Grayson, Sarah K. Tasian, Andrew S. Moore, Frank Keller, Melissa Frei‐Jones, James A. Whitlock, Elizabeth A. Raetz, Deborah L. White, Timothy P. Hughes, Jaime M. Guidry Auvil, Malcolm A. Smith, Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Jessica Kohlschmidt, Wendy Stock, Steven M. Kornblau, Marina Konopleva, Elisabeth Paietta, Ching‐Hon Pui, Sima Jeha, Mary V. Relling, William E. Evans, Daniela S. Gerhard, Julie M. Gastier-Foster, Elaine R. Mardis, Richard K. Wilson, Mignon L. Loh, James R. Downing, Stephen P. Hunger, Cheryl L. Willman, Jinghui Zhang, Charles G. Mullighan - New England Journal of Medicine 2014 被引用: 1,376

  4. Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    著者: , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,191

  5. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

    著者: , , , , , , , , , , - Leukemia 2008 被引用: 581

  6. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 198

  7. Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 255

  8. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 380

  9. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen P. Hunger, Mignon L. Loh, Rupert Handgretinger, Kim E. Nichols, Jun J. Yang, Charles G. Mullighan - Cancer Cell 2018 被引用: 205

  10. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

    著者: , , , , , , , , , , , , , , , - Blood 2023 被引用: 58

  11. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David T. Teachey, Elizabeth A. Raetz, Mignon L. Loh - New England Journal of Medicine 2024 被引用: 178

  12. Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation

    著者: , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 131

  13. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 237

  14. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

    著者: , , , , , , , , , , , , - Blood 2008 被引用: 835

  15. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2014 被引用: 449

  16. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deepa Bhojwani, Ching‐Hon Pui, William E. Evans, Mary V. Relling, Stephen P. Hunger, Cheryl L. Willman, Charles G. Mullighan, Jun J. Yang - Nature Genetics 2013 被引用: 308

  17. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 250

  18. Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 101

  19. Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients

    著者: , , , , - JNCI Journal of the National Cancer Institute 2021 被引用: 73

  20. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meenakshi Devidas - The Lancet Haematology 2023 被引用: 66

  21. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

    著者: , , , , , , , , , , , , , , , , - Blood 2017 被引用: 227

  22. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun J. Yang - Journal of Clinical Oncology 2018 被引用: 175

  23. Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 185

  24. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631

    著者: , , , , , , , , , , , , , , , , - Leukemia 2021 被引用: 92